Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Andre Okanobo"'
Autor:
Sheng Fu Cheng, Mohammad H. Dastjerdi, Francisco Amparo, Giulio Ferrari, Nambi Nallasamy, Reza Dana, Andre Okanobo
Publikováno v:
Cornea. 32:992-997
PURPOSE To examine the effect of topical ranibizumab on clinically stable corneal neovascularization (NV). METHODS This was a prospective, open-label, monocentric, uncontrolled noncomparative study. Ten eyes of 9 patients with corneal NV received top
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88f75e9d07d84778bc43529439a36762
https://doi.org/10.1097/ico.0b013e3182775f8d
https://doi.org/10.1097/ico.0b013e3182775f8d
Autor:
Andre Okanobo, Mohammad H. Dastjerdi, Francisco Amparo, Giulio Ferrari, Debra A. Schaumberg, Ula V. Jurkunas, Pedram Hamrah, Leila Smaga, Reza Dana
The immunopathogenic mechanisms of dry eye disease (DED), one of the most common ophthalmic conditions, is incompletely understood. Data from this prospective, double-masked, randomized trial demonstrate that targeting interleukin 1 (IL-1) by topical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e238d4fe7c6b3e8fb3d9d3855a2e7f85
https://europepmc.org/articles/PMC4167802/
https://europepmc.org/articles/PMC4167802/
Autor:
Sheng-Fu, Cheng, Mohammad H, Dastjerdi, Giulio, Ferrari, Andre, Okanobo, Francisco, Amparo, William, Stevenson, Pedram, Hamrah, Nambi, Nallasamy, Reza, Dana, Kraig S, Bower, Denise S, Ryan
Publikováno v:
American journal of ophthalmology. 156(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::63ca0da54fa00ef2e0e5fbb7114b7265
https://pubmed.ncbi.nlm.nih.gov/23791374
https://pubmed.ncbi.nlm.nih.gov/23791374
Autor:
Reza Dana, Jing Hua, Thomas H. Dohlman, William G. Stevenson, Sunil K. Chauhan, Zahra Sadrai, Andre Okanobo, Francisco Amparo, Yihe Chen
Publikováno v:
Investigative ophthalmologyvisual science. 53(7)
To determine the effect of phosphodiesterase type-4 (PDE4) inhibition on IL-17-associated immunity in experimental dry eye disease (DED).Murine DED was induced, after which a PDE4 inhibitor (cilomilast), dexamethasone, cyclosporine, or a relevant veh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5076ca7a7078306247d720d5ab12b1d8
https://pubmed.ncbi.nlm.nih.gov/22577075
https://pubmed.ncbi.nlm.nih.gov/22577075
Purpose To evaluate the therapeutic efficacy of topical interleukin-1 receptor antagonist (IL-1Ra) in the treatment of dry eye disease. Design Laboratory investigation. Methods Dry eye disease was induced in C57BL/6 female mice through exposure to a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1d87ae205362802163734463c9b7751
https://europepmc.org/articles/PMC3378826/
https://europepmc.org/articles/PMC3378826/
Publikováno v:
Cornea. 30(12)
To study the efficacy of topical epigallocatechin gallate (EGCG) for the treatment of dry eye disease (DED).Seven- to 8-week-old female C57BL/6 mice were housed in the controlled environment chamber to induce DED. Topical 0.01% or 0.1% EGCG, or vehic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc690017db559ef445f51df6f675907a
https://pubmed.ncbi.nlm.nih.gov/21993466
https://pubmed.ncbi.nlm.nih.gov/21993466
NK cells have been increasingly reported to be an important effector in autoimmune diseases. However, nothing is known in this regard in DED, the most common eye pathology, which is characterized by sustained inflammation on the ocular surface. In th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64f33889da46380712c9e36a52819412
https://europepmc.org/articles/PMC3100760/
https://europepmc.org/articles/PMC3100760/
Autor:
Andre Okanobo, Denise S. Ryan, Kraig S. Bower, William Stevenson, Mohammad H. Dastjerdi, Francisco Amparo, Giulio Ferrari, Reza Dana, Pedram Hamrah, Nambi Nallasamy, Sheng Fu Cheng
Publikováno v:
American Journal of Ophthalmology. 154:940-948.e1
Purpose To evaluate the safety and efficacy of topical bevacizumab in the treatment of corneal neovascularization. Design Prospective, nonrandomized, interventional case series. Methods setting: Institutional, multicenter clinical trial. study popula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0963028bf26f030b10154fe2f477103c
https://doi.org/10.1016/j.ajo.2012.06.007
https://doi.org/10.1016/j.ajo.2012.06.007
Autor:
Zahra Sadrai, Daniel R. Saban, Amir Reza Hajrasouliha, Reza Dana, Sunil K. Chauhan, Mohammad Dastjerdi, Nambi Nallasamy, Andre Okanobo
Publikováno v:
Investigative Opthalmology & Visual Science. 51:2411
Allograft rejection is a leading cause of corneal graft failure and thus a leading indication for repeat penetrating keratoplasty.1 Indeed, repeat grafting as a result of previous failure has become the second leading indication for corneal transplan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::945d2423fd5fb255096c50e6a58f7a4e
https://doi.org/10.1167/iovs.09-3745
https://doi.org/10.1167/iovs.09-3745